Insights from HBM4EU-Mom
Can human biomonitoring, combined with fish consumption advice to pregnant women, help control prenatal exposure to mercury?
As part of the on-going preparations for the second segment of the Minamata Convention on Mercury which will be held in Bali at the end of the month, HBM4EU has put together a panel of experts dedicated to the HBM-Mom study which focuses on reducing prenatal exposure to mercury via dietary advice for pregnant women in 5 European coastal countries.
List of speakers:
Dr. Andromachi Katsonouri, Ministry of Health, Cyprus
Dr. Spyros Karakitsios, Aristotle University of Thessaloniki, Greece
Dr. Catherine Gabriel, (HBM4EU-MOM in Greece)
Dr Marta Esteban López, (HBM4EU-MOM in Spain)
Dr Þórhallur Ingi Halldórsson, (HBM4EU-MOM in Iceland)
Dr Sónia Namorado, (HBM4EU-MOM in Portugal)
Prof Denis Sarigiannis, Panelist
Argelia Castaño Calvo, Panelist
Register via this link to learn more about the study and join us on Wednesday, 9th of March from 15:30–16:30.
The HBM4EU project was launched in 2016 with the aim of improving the collective understanding of human exposure to hazardous chemicals and developing HBM as an exposure assessment method. The project had €74m in funding and jointly implemented by 120 partners from 28 participating countries – 24 EU member states plus Norway, Switzerland, Iceland and Israel and the European Environment Agency. One of its aims was to ensure the sustainability of HBM in the EU beyond 2021. The project ended in June 2022. The website will not be updated any longer, except the page on peer reviewed publications, but will be online until 2032.